AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

MVM Partners LLP Closes MVM V

January 8, 2020 GMT

BOSTON & LONDON--(BUSINESS WIRE)--Jan 8, 2020--

MVM Partners today announced the closing of a $325 million healthcare fund, MVM V.

MVM has been investing in high growth healthcare businesses since 1997 and this latest fund, MVM V, will continue this broad, global, investment remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, and digital health in both private deals and quoted companies. Typical projected investment in each company is $20 to $40 million, but with capacity for larger investments.

In aggregate, MVM has raised investment vehicles totaling over $1 billion which are managed from offices in Boston and London. For more information visit www.mvm.com.

This press release, together with any information or documents accompanying it, is issued by MVM Partners LLP, which is authorised and regulated in the UK by the Financial Conduct Authority.

This document does not constitute an offer or invitation to subscribe or purchase limited partnership interests. Any investment in MVM V LP will be made solely on the basis of the private placement memorandum issued in connection therewith and the limited partnership agreement and associated documentation.

View source version on businesswire.com:https://www.businesswire.com/news/home/20200107005677/en/

CONTACT: MVM Partners LLP

Dr Stephen Reeders

sr@mvm.com

Dr Eric Bednarski

eb@mvm.comMr Thomas Casdagli

tc@mvm.com

KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: PROFESSIONAL SERVICES MEDICAL DEVICES HEALTH FINANCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: MVM Partners LLP

Copyright Business Wire 2020.

PUB: 01/08/2020 02:00 AM/DISC: 01/08/2020 02:01 AM

http://www.businesswire.com/news/home/20200107005677/en